Overall market situation:
The mood on the European stock exchanges is mixed, but price movements remain within a fairly narrow range; the UK market is closed, the German DAX is gaining 0.76%, while the French CAC40 is losing 0.57%.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe economic calendar for today's session focuses on the ISM PMI data for services from the US and quarterly reports from companies such as Palantir, Ford and Realty Income.
Distribution of today's returns for companies from Europe. Source: xStation
The German DE40 index is gaining 0.31% today on an intraday basis. The contract is holding above the 50-day EMA (blue line) and completely erasing the declines that started at the end of March. From a technical perspective (exponential EMA), the DE40 is resuming its upward trend and is already almost in the zone of historical highs. Source: xStation
News:
Novo Nordisk (NOVOB.DK) is up 0.7% after the FDA accepted the company’s application for oral Semaglutide 25 mg, which if approved would be the first oral GLP-1 treatment for obesity.
Volkswagen AG’s (VOW1.DE) Audi brand continues to struggle with low returns amid subdued demand in Europe and increasing competition in China. Despite this, the brand’s operating margin was 1.5% in the first quarter, a slight improvement from 1.1% in the same period last year. Furthermore, Audi’s revenue in Q1 was €15.43 billion, up 12.4% year-on-year. The brand delivered a total of 388,756 vehicles in Q1, down 3.3% year-on-year.
Shell (SHELL.NL) is working with advisers to evaluate a potential takeover of rival BP (BP.UK), but is waiting for further declines in stock and oil prices before deciding whether to make a bid, Bloomberg News reported Saturday, citing people familiar with the matter. The Dutch company’s shares are down nearly 2% today.
Other corporate news. Source: Bloomberg Financial LP
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
